SCHEMBL2586864

SCHEMBL2586864

Cc1cccc2c1N(C)c1ccccc1S2

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.64
BCHE P06276 11/20 0.50
NOX1 Q9Y5S8 3/20 0.50
L3MBTL1 Q9Y468 2/20 0.49
MEN1 O00255 1/20 0.49
ADRA2A P08913 1/20 0.49
ADRA2B P18089 1/20 0.49
ADRA2C P18825 1/20 0.49
CHRM3 P20309 1/20 0.49
SLC6A2 P23975 1/20 0.49
HTR2C P28335 1/20 0.49
SLC6A4 P31645 1/20 0.49
DRD3 P35462 1/20 0.49
HTR2B P41595 1/20 0.49
KMT2A Q03164 1/20 0.49
MAPT P10636 2/20 0.44
LMNA P02545 1/20 0.44
MAPK1 P28482 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
ALDH1A1 P00352 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1720092 0.83 MAOA (0.50) MAOABCHENOX1L3MBTL1MEN1
SCHEMBL16892119 0.82 MAOA (0.60) MAOABCHENOX1L3MBTL1MEN1
SCHEMBL29377505 0.80 MAOA (1.00) MAOABCHENOX1L3MBTL1MEN1
SCHEMBL231247 0.80 MAOA (1.00) MAOABCHENOX1L3MBTL1MEN1
SCHEMBL628362 0.78 MAOA (0.64) MAOABCHENOX1L3MBTL1MEN1
SCHEMBL7122154 0.77 MAOA (0.58) MAOABCHENOX1L3MBTL1MEN1
SCHEMBL6651734 0.77 MAOA (0.58) MAOABCHENOX1L3MBTL1MEN1
SCHEMBL16079005 0.76 ALDH1A1 (0.38) MAOABCHENOX1MEN1KMT2A
SCHEMBL627989 0.74 MAOA (0.70) MAOABCHENOX1L3MBTL1MEN1
SCHEMBL628765 0.74 MAOA (0.70) MAOABCHENOX1L3MBTL1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2585073-B1 ANTIVIRAL COMPOUNDS PROSETTA ANTIVIRAL INC (US) 2016-04-27 EP disclosed
US-8785434-B2 Antiviral compounds PROSETTA ANTIVIRAL INC. (US) 2014-07-22 US disclosed
EP-2585073-A1 ANTIVIRAL COMPOUNDS Prostetta Antiviral Inc. (US) 2013-05-01 EP disclosed
US-20120157435-A1 Antiviral Compounds PROSETTA ANTIVIRAL INC. (US) 2012-06-21 US disclosed
WO-2011137447-A1 ANTIVIRAL COMPOUNDS PROSTETTA ANTIVIRAL INC. (US) 2011-11-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120157435-A1 Antiviral Compounds MAVS, ZC3HAV1, EIF2AK2 MAOA 1309/4885BCHE 1570/4885NOX1 2140/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.